Theratechnologies Inc T.TH

RE:RE:Best PR guys

[qwerty22]

I think the cancer study is just too early to be generating much data either way. Doses are likely to be too low to be impacting safety or efficacy, although we might now be reaching dose levels that matter. Then again something interesting might have occurred in the low doses, who knows?

The Facebook post is from the clinical co-ordinator at Gettysburg. Would he be publically gushing about a clinical trial if it had gone belly up? I think we can be certain that up to the 10th May that everything was on track. Since then they've put out calls for pancreatic cancer patients for trials and then colon cancer, neither was specifically linked to the THTX trial but I could imagine they are keen to get those two groups enrolled into the SORT1 trial based on the preclinical data.

SPCEO1 wrote: By this point, we must have several patients in the MTD portion of the study. I find it quite odd that Paul indicated he is not aware of what is going on in an open-label study. Would Gettysburg and other clinics refuse to report info back for a period of time? Would there be some internal procedure to block the CEO from learning the status until a certain amount of data was collected? Is this normal? If not, what is going on? Or is Paul pretending not to know as part of a larger strategy to release the info at a time when it is viewed to be most advantageous to TH? I could imagine that LSA might want to hit the ground with a big bang of both the NASH  phase III protocol and an important update on the cancer phase I in a way which they believe will maximize the exposure for TH.  

Or, it could be that the cancer news is not good at the moment and they are hoping to gather more data which will change the way things look for the better before reporting anything. 
 

qwerty22 wrote: From back on 10 May on Gettysburg cancer centre Facebook page. I feel like these guys are more excited about the trial than THTX. We should keep an eye on this, they've put out calls for trial patients regularly, I hope it's mostly for THTX's trial.

Looks like 3 sites should be active now.

https://www.facebook.com/GettysburgCancerCenter/

“I’ve been doing clinical cancer research close to 20 years, and in all that time I’ve never seen a phase 1 study receive fast-tracked FDA approval prior to dosing patients.

To have that happen here at Gettysburg Cancer Center with the Theratechnologies study on solid cancer tumors is exciting. We are currently still the only site in the world offering this clinical trial, with two additional U.S. sites opening this month. Still, to bring this cutting-edge technology to Gettysburg first, world-wide, is gratifying to an extreme degree.”

-Terry Burke, Clinical Research Coordinator, GCC

Our innovative trials attract local, regional, national and even international cancer patients. Contact us for more information about available clinical trials: